Is Exxua (Gepirone) in a drug shortage in 2026? Get the latest on availability, pricing, and what patients can do to find Exxua at their pharmacy.
If you've been trying to fill an Exxua (Gepirone) prescription and keep hitting dead ends, you're probably asking: is Exxua in a shortage? The short answer is no — Exxua is not listed on the FDA's official drug shortage list. But the reality on the ground feels a lot like a shortage for many patients.
Here's what's actually happening with Exxua availability in 2026 and what you can do about it.
Exxua was FDA-approved in September 2023, but it didn't become commercially available until January 20, 2026, when Aytu BioPharma launched it nationwide. That means the drug has only been on pharmacy shelves for a few months.
Unlike established antidepressants that are stocked at every corner pharmacy, Exxua is distributed primarily through the Aytu RxConnect pharmacy network — a network of over 1,000 participating pharmacies across the country. Major retail chains like CVS and Walgreens may not carry it, or may need to special-order it.
So while there isn't a manufacturing shortage, the limited distribution footprint means many patients can't find Exxua at their usual pharmacy. For a deeper look at the reasons, read why Exxua is so hard to find.
Several factors contribute to the current availability challenges:
Exxua is one of the newest drugs on the market. Aytu BioPharma is still scaling up its distribution network. Not every pharmacy has established ordering relationships with Exxua's distributor yet, and some pharmacists may not even know the drug is available.
As a brand-name medication with no generic alternative, Exxua often requires prior authorization from insurance companies. Some plans also require step therapy, meaning patients must try and fail on cheaper antidepressants before Exxua is covered. These delays reduce demand signals to pharmacies, which in turn discourages stocking.
At approximately $1,500 to $1,800 per month without insurance, Exxua's cash price is a barrier for patients paying out-of-pocket. Pharmacies may be hesitant to stock an expensive new medication if they're unsure about demand.
The retail cash price for Exxua varies by dosage strength:
There is no generic version of Gepirone available. NCE exclusivity runs through September 2028, so generics won't be available before then.
The Aytu RxConnect program may offer reduced pricing at participating pharmacies. For more savings strategies, see our guide on how to save money on Exxua.
Yes — the antidepressant landscape is evolving. While Exxua is the newest oral antidepressant for MDD, several other options have also become available in recent years:
If Exxua isn't available to you right now, these alternatives may be worth discussing with your doctor. We cover this topic in depth in our post on alternatives to Exxua.
Here are the most effective strategies for finding Exxua right now:
For the full playbook, read our guide on how to find Exxua in stock near you.
Exxua isn't in a formal drug shortage, but limited distribution and high demand for a genuinely new kind of antidepressant mean that finding it takes more effort than filling a typical prescription. The situation is improving as Aytu BioPharma expands its pharmacy network throughout 2026.
In the meantime, don't go without treatment. Use Medfinder to track down stock, work with your doctor on insurance hurdles, and consider alternatives if you need to start treatment right away.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
